Backgroud Chronic hepatitis is the major infectious disease of liver. There is no effective drug for it up to now. Clinical trials have showed that glycyrrhizin have potentional effective for chronic hepatitis. Objective To evaluate the effectiveness, safety and economics of glycyrrhizin for chronic hepatitis B and C. Search strategy The search terms include glycyrrhizin and its products’ name, chronic hepatitis and chronic carrier status. The thais registers of the Cochrane Hepato-Biliary Group, the Cochrane Complementary Medicine Field, and the central database of The Cochrane Library as well as MEDLINE, EMBASE and Chinese Biomedical CD Database were searched from their date of inception onward. And the free Internet search was operated to find ongoing and unpublished researches. Twenty Chinese medical journals and relevant academic conference proceedings have been searched by manual method. The reference lists of identified documents were checked as the complementary search. Inclusion criteria All randomized trials that tested glycryyhizin for chronic hepatitis B virus or hepatitis C virus infection were included in this review. Method of the review According to the principle of Cochrane systematic review, selection of thai for inclusion, assessment of methodological quality, data extraction and data syntheses were conducted by two reviewers.
Objective To investigate the effectiveness of radical debridement, reconstruction with bone allograft, and pedicle screw-rod internal fixation via combined anterior and posterior approach in the treatment of lumbosacral tuberculosis. Methods Between January 2005 and May 2010, 16 patients with lumbosacral tuberculosis were treated. Radical debridement wasperformed via extraperitoneal approach, then tricortical il iac bone allograft was placed and pedicle screw-rod internal fixation was used to reconstruct the spinal column. There were 12 males and 4 females aged 38-65 years (mean, 48 years). The disease duration ranged from 6 to 24 months (mean, 10 months). The main cl inical symptom was persistent pain in lumbosacral area. The involved segments included L4, 5 (3 cases), L5, S1 (8 cases), and L4-S1 (5 cases). The lumbosacral angle was 18-32° (mean, 22°). The erythrocyte sedimentation rate (ESR) was 15-55 mm/1 hour (mean, 25 mm/1 hour). All the patients were given antituberculosis chemotherapy for 12 months after operation. Results The operation time was 120-240 minutes (mean, 180 minutes). The amount of bleeding was 300-600 mL (mean, 420 mL). All wounds healed by first intention, and no relative compl ication occurred. All 16 cases were followed up 12-24 months (mean, 16 months). No recurrence occurred and ESR recovered to normal. Persistent pain in lumbosacral area and radicular pain in lower extremities disappeared. The X-ray films demonstrated that bony fusion was obtained in all patients at 8-12 months postoperatively. The lumbosacral angle was 16-31° (mean, 21°) at last follow-up. Conclusion The extraperitoneal approach can provide direct and safe access to the lesion. The structural il iac bone allograft and posterior instrumentation could reconstruct effectively the stabil ity of the lumbosacral junction.
Objective To collect the report guidelines for systematic reviews and meta-analyses, so as to provide support for the standardized publish and spread of those guidelines. Methods Such databases as Ovid MEDLINE (1996-2010) and EMbase (till April, 2010) were searched with the terms of “guideline”, “report”, “systematic review” and “meta-analysis” to collect the report guidelines for systematic reviews and meta-analyses. The irrelevant literatures (e.g. systematic review of a specific disease, clinical guideline for a certain disease, and other literatures focusing on the methodology of systematic review without mentioning reporting guideline) were excluded by reading the abstracts and titles, and then the further verification was done after the full-texts had been read. The contents about how to report a systematic review or meta-analyses were extracted from the included studies which were classified by its form of the original research (e.g. randomized controlled trial, observational study, diagnostic trial, etc.). Results Primary search ended up with 285 literatures, and 26 literatures of which were included. Among the included literatures about the report guidelines for systematic reviews and meta-analyses, eight were about RCTs, two about non-RCTs, two about observational study, no literature about diagnostic trial, one about animal experiment, two about report searching strategy, five about quality assessment, six about the influence on quality, and the other two about the update of guidelines. Conclusion The report guidelines for systematic reviews and meta-analyses are considerable in number, among which the QUOROM and its updated version PRISMA are relatively mature and widely applied. Report guidelines are beneficial to improve the quality of systematic reviews and meta-analyses, and the report guideline focusing on specific field is needs to be formulate.
New interventions are rapidly progressing into clinical practice through the preclinical study stage. The animal experiments should be comprehensive and critically evaluated for their pivotal role in this process. To integrate the evidence of animal studies by systematic review throws light on intervention outcomes and could decrease risk of participants in human trials. The methodological weakness of animal studies is easy to highlight but robust methods to synthesize evidence is essential. Here, we discuss some problems in systematic review of animal experiments and whether animal models of diverse species contribute to bias of meta-analysis conclusions.
The quality of reporting of randomized clinical trials could be significantly improved by the application of CONSORT （Consolidated Standards of Reporting Trials） statement. We compared and analyzed the difference of acceptance of CONSORT statement between Chinese medical journals and Western medical journals, and proposed to disseminate and apply CONSORT statement to improve the quality of reporting of randomized clinical trials and medical journals.